Alvino Maestri

Antonio Maestri 3 collaborations

Lorenzo Gianni 2 collaborations

Fabio Canino 1 collaboration

Monica Barbolini 1 collaboration

Ugo De Giorgi 1 collaboration

Tommaso Fontana 1 collaboration

Valeria Gaspari 1 collaboration

Caterina Gianni 1 collaboration

Santino Minichillo 1 collaboration

Luca Moscetti 1 collaboration

Antonella Mura 1 collaboration

Stefania Vittoria Luisa Nicoletti 1 collaboration

Claudia Omarini 1 collaboration

Rachele Pagani 1 collaboration

Samanta Sarti 1 collaboration

Angela Toss 1 collaboration

Claudio Zamagni 1 collaboration

Riccardo Cuoghi Costantini 1 collaboration

Federica Caggia 1 collaboration

Giuseppina Antonelli 1 collaboration

Federica Baglio 1 collaboration

Lorenzo Belluzzi 1 collaboration

Giulio Martinelli 1 collaboration

Salvatore Natalizio 1 collaboration

Ornella Ponzoni 1 collaboration

Massimo Dominici 1 collaboration

Federico Piacentini 1 collaboration

Marco Pellegrini 1 collaboration

Carlotta Senni 1 collaboration

Federico Bernabei 1 collaboration

Arrigo F G Cicero 1 collaboration

Aldo Vagge 1 collaboration

Vincenzo Scorcia 1 collaboration

Giuseppe Giannaccare 1 collaboration

Andrea Rocca 1 collaboration

Pietro Cortesi 1 collaboration

Laura Cortesi 1 collaboration

Federica Matteucci 1 collaboration

Lorenzo Fantini 1 collaboration

Donata Casadei Giunchi 1 collaboration

Luigi Cavanna 1 collaboration

Rosa Ciani 1 collaboration

Fabio Falcini 1 collaboration

Antonella Bagni 1 collaboration

Elena Meldoli 1 collaboration

Monia Dall'Agata 1 collaboration

Roberta Volpi 1 collaboration

Daniele Andreis 1 collaboration

Oriana Nanni 1 collaboration

Annalisa Curcio 1 collaboration

Leonardo Lucchi 1 collaboration

Dino Amadori 1 collaboration

Anna Fedeli 1 collaboration

Publications (3)

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.

The Role of Nutrition and Nutritional Supplements in Ocular Surface Diseases.

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.

Réseau de co-auteurs